Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12644314 | 0.89 | TSHR (0.67) | TSHREPHX1KCNA3GAATDP1 | |
| SCHEMBL18123391 | 0.88 | TSHR (0.59) | TSHREPHX1TDP1 | |
| SCHEMBL13573768 | 0.86 | TSHR (0.63) | TSHREPHX1TDP1MAPT | |
| SCHEMBL21667490 | 0.86 | TSHR (0.63) | TSHREPHX1TDP1MAPT | |
| SCHEMBL12862502 | 0.86 | TSHR (0.63) | TSHREPHX1TDP1MAPT | |
| SCHEMBL12172788 | 0.86 | TSHR (0.63) | TSHREPHX1TDP1MAPT | |
| SCHEMBL16131273 | 0.86 | TSHR (0.57) | TSHRKCNA3 | |
| SCHEMBL13413671 | 0.85 | TSHR (0.47) | TSHREPHX1 | |
| SCHEMBL21657466 | 0.84 | TSHR (0.55) | TSHREPHX1 | |
| SCHEMBL20887867 | 0.84 | TSHR (0.55) | TSHREPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |